Precision Medicine: Tailoring Healthcare to Individual Needs

Antoine Geissbuhler is a distinguished Professor of Medicine and the Vice-Rector in charge of Digital Transformation and Innovation at the University of Geneva. He also serves as the Director of the Division of eHealth and Telemedicine at Geneva University Hospitals and leads the hospitals' Innovation Center. With a commitment to enhancing healthcare through technology, Geissbuhler has made significant contributions as the Past-President of the International Medical Informatics Association and a Fellow of the American College of Medical Informaticians.

Professor Idris Guessous is the Head of the Division of Primary Care Medicine at the University Hospitals of Geneva (HUG) and has a distinguished background in medicine and epidemiology. He earned his medical degree in 2001 from the University of Lausanne, followed by clinical and epidemiological training, a doctorate in medicine, and specialization in general internal medicine. He furthered his education with a PhD in epidemiology at Emory University, where he also completed a fellowship at the Centers for Disease Control and Prevention (CDC) in Atlanta. Since joining HUG in 2009 as the head of the population epidemiology unit, he has focused on studying health determinants, including genetic and environmental factors. Professor Guessous has authored over 200 scientific articles and is actively involved in various national and international population-based studies. He co-founded the GIRAPH research group, which integrates geographic information into public health research. His leadership extends to multiple projects aimed at improving public health, including being the principal investigator for a European clinical trial on post-COVID syndrome. In addition to his clinical responsibilities, he serves on the executive committee of the Swiss Society of General Internal Medicine and is an academic editor for the Swiss Medical Weekly. Recently appointed as Vice-Dean for postgraduate education at UNIGE Faculty of Medicine, he is committed to advancing medical education and research in primary care.

Dr. Caroline Samer is the Head of the Pharmacogenomics and Personalized Therapy Unit in the Clinical Pharmacology and Toxicology Department at Geneva University Hospitals (HUG) and a Professor of Clinical Pharmacology and Toxicology at the University of Geneva. She chairs the clinical division of the International Union for Basic and Clinical Pharmacology (IUPHAR) and focuses on promoting precision medicine approaches in her clinical and teaching activities. Dr. Samer's research aims to personalize drug therapy by investigating gene-environment-disease interactions at the pharmacokinetic level, utilizing advances in various -omics technologies, particularly pharmacogenomics. She has authored numerous scientific publications and is actively involved in multiple national and international collaborations. Dr. Samer received her medical degree from the University of Geneva in 2001, followed by specialization in internal medicine and clinical pharmacology, culminating in a PhD in pharmacogenomics. In addition to her leadership roles, she serves on several editorial boards and has received various grants to support her research initiatives.

Dr. Christelle Borel is a Privat-Docent and Senior Research Associate at the University of Geneva, specializing in Human Genomics and Genetics. She earned her Ph.D. in Life Sciences from Lyon University in France in 1998. Her research focuses on exploring the relationship between inter-individual genomic variation and phenotypic variability, aiming to identify genetic variants associated with diseases. In addition to her research, Dr. Borel leads the Human Genetics and Genomics graduate training programs at the Faculty of Medicine, where she is committed to educating the next generation of scientists in this vital field. Her contributions to genetics research and education are significant, reflecting her dedication to advancing understanding in human health and disease.

Dr. Petros Tsantoulis is a Senior Clinical Associate at the University of Geneva, where he plays a pivotal role in the development of precision oncology at the university hospital. He obtained his medical degree and PhD in Athens before specializing in internal medicine and medical oncology in Switzerland. Dr. Tsantoulis is also a lab leader at the Center for Translational Hemato-Oncology, focusing his research on biomarker development for various cancer types. His work aims to enhance personalized medicine by identifying genetic alterations that inform cancer prognosis and treatment responses. He utilizes advanced analytical techniques, including DNA/RNA sequencing, to explore the molecular features of tumors and their implications for clinical decision-making. Dr. Tsantoulis is actively involved in collaborative efforts with national networks and has contributed significantly to the field through numerous publications and participation in molecular tumor boards that integrate expert insights from oncology, pathology, genetics, and bioinformatics.